TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Clinical trial NCT04701476 · RECRUITING

Trial details

NCT number: NCT04701476
Sponsor: Teclison Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer; Lung Cancer

Start date: 2021-05-20
Primary completion: 2027-03-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.